Agenda Archive

CASE STUDY: Making a strategic success of public-private partnerships

Exploring different funding avenues: how to structure fundraising initiatives
Working in collaboration with academia: benefits and opportunities
The importance of building networks and insights from investors in addition to capital
Lessons learned: analyzing both successes and learnings for future biotech initiatives

Opportunities for incorporating AI into clinical research: where should the industry be focusing?
Why has pharma been relatively slow to utilize AI in clinical research?
Understanding limitations of GenAI: what do you need to be wary of?
Real case studies on AI in the clinical trial industry: where has there been progress and success?
What does the future hold for AI in clinical trials?

MODERATOR Revati Tatake, Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Healthcare

Big pharma is a battleship in a speedboat world. FSP outsourcing offers the agility to cut through traditional development timelines and chart a faster course to patients.
In this presentation, Parexel will share how they partnered with Bristol Myers Squibb (BMS) to make a strategic shift, transitioning from a predominantly full-service outsourcing model to a functional service provider model. This involved redefining traditional roles, innovating tasks and responsibilities, and talent redeployment in support of pipeline priorities.
The presenters will discuss the strategic considerations and benefits of this transition, demonstrating how through a collaborative partnership, they worked to enhance BMS’ clinical trial operations, creating resource efficiencies, increasing agility, and optimizing clinical operations across their global portfolio. This presentation will offer valuable insights for companies seeking to adapt their outsourcing strategies to meet the demands of today’s complex and rapidly changing drug development environment.

Harnessing Apple Watch technology: key features for detecting heart arrhythmias
What the evidence says: insights from published cardiovascular studies
From wrist to research: smart distribution models for clinical trial success
Making it work: tackling operational and data management hurdles for clinical trial success

What is realistic, what isn’t, and how can you stay ahead of the curve?
How biotech and pharma differ when it comes to technology and innovation: as a biotech, where should your priorities lie?
Staying ahead of competitors when funding and resources are limited for technology investment
Leveraging agility and flexibility to adopt technology quickly
Balancing innovation with risk management and scalable development

MODERATOR Jay Russak, Former Senior Director, Clinical Operations, Keros Therapeutics

Uncovering the invisible: a 20-year analysis of medically underrepresented populations in clinical trials
Benchmarking against the US census reveals structural gaps and needs
Adopt a six-pillar architecture to embed equity from the ground up

Streamlining feasibility, site selection and qualification processes to minimize delays
Leveraging technology to manage documents, workflows and communication
Identifying common bottlenecks and strategies to overcome them proactively
Aligning sponsor, CRO and site teams to ensure clarity from day one